|
市場調査レポート
商品コード
1110908
医療用食品の世界市場-用途別、タイプ別、販売チャネル別、地域別展望、競合戦略、2030年までのセグメント別予測Global Medical Foods Market- By Application, By Type, By Sales Channel -Regional Outlook, Competitive Strategies and Segment Forecasts to 2030 |
||||||
|
|
|||||||
| 医療用食品の世界市場-用途別、タイプ別、販売チャネル別、地域別展望、競合戦略、2030年までのセグメント別予測 |
|
出版日: 2022年08月08日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 249 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 目次
世界の医療用食品の市場規模は、今後5.5％のCAGRで拡大し、2030年までに343億2,000万米ドルに達すると予測されています。
当レポートでは、世界の医療用食品市場について調査し、市場の概要とともに、用途別、タイプ別、販売チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
第1章 イントロダクション
第2章 調査手法
第3章 エグゼクティブサマリー
第4章 市場力学
- 促進要因、抑制要因、機会、課題の分析
- 促進要因
- 抑制要因
- 機会
- 課題
- COVID-19が世界の医療用食品市場に及ぼす影響
第5章 市場変数と見通し
- SWOT分析
- PESTEL分析
- ポーターのファイブフォース分析
- ヒートマップ分析
第6章 世界の医療用食品市場、用途別、2019年～2030年（100万米ドル）
- アルツハイマー病
- 糖尿病性神経障害
- 栄養不足
- ADHD
- その他
第7章 世界の医療用食品市場、タイプ別、2019年～2030年（100万米ドル）
- 丸薬
- 粉末
- その他
第8章 世界の医療用食品市場、販売チャネル別、2019年～2030年（100万米ドル）
- 小売販売
- オンライン販売
- 機関販売
第9章 世界の医療用食品市場、地域別、2019年～2030年（100万米ドル）
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
第10章 企業プロファイル
- Abbott Laboratories
- Cerecin Inc.
- Danone
- Fresenius SE & Co.
- Meiji Holdings & Co. Ltd.
- Metagenics Inc.
- Nestle
- Primus Pharmaceuticals Inc
- Reckitt Benckiser Group
- Targeted Medical Pharma Inc
According to SPER Market Research, the Global Medical Foods Market is estimated to reach USD 34.32 billion by 2030 with a CAGR of 5.5%.
The medical foods market consists of sales of medical foods by entities (organizations, sole traders, and partnerships) that refer to foods, which are formulated to be administered or consumed under the presence of a physician, and it is intended to provide specific dietary management of a disease for which nutritional requirements are established by medical evaluation. Medical food pills are specially formulated to meet the nutritional requirements of patients with various medical conditions such as digression, ADHD, and others. They are used in the treatment of Alzheimer's disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, and others. As people get old, their dependency on certain nutritional foods increases especially medical foods to manage their health from chronic and age-related diseases.
The companies operating in the medical foods sector are developing innovative products with greater efficacy to cater to the demand from customers with specific niche diseases such as metabolic disorders, ADHD, and others.
Major players in the medical foods market are: Nestle, Fresenius Se & Co., Danone, Primus Pharmaceuticals Inc., Abbott Laboratories, Metagenics Inc., Targeted Medical Pharma Inc.
Impact of COVID-19 on the Global Medical Foods Market:
The report delivers insights on COVID-19 considering the changes in consumer behaviour and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments.
Scope of the report:
Report Metric Details
- Market size available for years: 2019-2030
- Base year considered: 2021
- Forecast period: 2022-2030
- Segments covered: By Application, By Type, By Sales Channel, By Region
- Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
- Companies Covered: Abbott Laboratories, Cerecin Inc., Danone, Fresenius SE & Co., Meiji Holdings and Co. Ltd., Metagenics Inc., Nestle, Primus Pharmaceuticals Inc., Reckitt Benckiser Group, Targeted Medical Pharma Inc.
Global Medical Foods Market, By Application:
Based on the application, Global Medical Foods Market is segmented as; Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Others.
Global Medical Foods Market, By Type:
Based on the type, Global Medical Foods Market is segmented as; Pills, Powder, Others.
Global Medical Foods Market, By Sales Channel:
Based on the sales channel, Global Medical Foods Market is segmented as; Retail Sales, Online Sales, Institutional Sales.
Global Medical Foods Market, By Region:
North America was the largest region in the medical foods market. Asia-Pacific is expected to be the fastest-growing region in the global medical foods market during the forecast period.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1 Research data source
- 2.1.1. Secondary data
- 2.1.2. Primary data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
- 2.2 Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Global Medical Foods Market
5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL analysis
- 5.2.1. Political landscape
- 5.2.2. Economic landscape
- 5.2.3. Social landscape
- 5.2.4. Technological landscape
- 5.2.5. Environmental landscape
- 5.2.6. Legal landscape
- 5.3. PORTER'S five forces analysis
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of Buyers
5.3.3.Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat map analysis
6. Global Medical Foods Market, By Application, 2019-2030 (USD Million)
- 6.1. Alzheimer's Disease
- 6.2. Diabetic Neuropathy
- 6.3. Nutritional Deficiency
- 6.4. ADHD
- 6.5. Others
7. Global Medical Foods Market, By Type, 2019-2030 (USD Million)
- 7.1. Pills
- 7.2. Powder
- 7.3. Others
8. Global Medical Foods Market, By Sales Channel, 2019-2030 (USD Million)
- 8.1. Retail Sales
- 8.2. Online Sales
- 8.3. Institutional Sales
9. Global Medical Foods Market, By Region, 2019-2030 (USD Million)
- 9.1. North America
- 9.1.1. United States
- 9.1.2. Canada
- 9.1.3. Mexico
- 9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
- 9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia-Pacific
- 9.4. South America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of South America
- 9.5. Middle East & Africa
- 9.5.1. Kingdom of Saudi Arabia
- 9.5.2. United Arab Emirates
- 9.5.3. Rest of Middle East & Africa
10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
- 10.2. Cerecin Inc.
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
- 10.3. Danone
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
- 10.4. Fresenius SE & Co.
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
- 10.5. Meiji Holdings & Co. Ltd.
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
- 10.6. Metagenics Inc.
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
- 10.7. Nestle
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
- 10.8. Primus Pharmaceuticals Inc.
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
- 10.9. Reckitt Benckiser Group
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
- 10.10. Targeted Medical Pharma Inc.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
